Rhythm Pharmaceuticals Ratios (2016-2025) | RYTM

Ratios Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 88.57%50.00%78.40%87.01%84.65%95.83%88.40%88.30%87.61%88.37%89.28%86.66%89.19%89.87%88.49%90.95%88.85%88.57%89.28%
EBT Margin 187,874.29%-14,748.54%-4,290.08%-2,798.84%-3,506.74%-494.40%-953.80%-483.42%-454.96%-242.98%-194.61%-170.99%-543.27%-109.30%-132.28%-103.71%-151.11%-95.45%-102.91%
EBIT Margin -98,280.00%-14,756.20%-4,303.50%-2,806.22%-3,517.42%-497.42%-916.60%-478.99%-458.03%-242.46%-195.31%-170.28%-538.71%-139.20%-131.98%-98.63%-143.73%-93.39%-102.64%
EBITDA Margin -98,280.00%-14,756.20%-4,303.50%-2,806.22%-3,517.42%-497.42%-916.60%-478.99%-458.03%-242.46%-195.31%-170.28%-538.71%-139.20%-131.98%-98.63%-143.73%-93.39%-102.64%
Operating Margin -98,280.00%-14,756.20%-4,303.50%-2,806.22%-3,517.42%-497.42%-916.60%-478.99%-458.03%-242.46%-195.31%-170.28%-538.71%-139.20%-131.98%-98.63%-143.73%-93.39%-102.64%
Net Margin 125,000.00%-12,915.69%-3,415.08%-2,798.84%-3,506.74%-494.40%-953.80%-483.42%-454.96%-271.47%-196.25%-171.80%-544.43%-115.42%-135.24%-106.70%-155.39%-98.93%-105.81%
FCF Margin -95,837.14%-11,710.95%-3,916.93%-2,231.15%-3,588.72%-428.73%-1,099.02%-386.79%-318.07%-213.78%-129.99%-121.24%-156.90%-99.99%-75.83%-45.05%-123.38%-48.07%-51.90%
Efficiency
Inventory Average 4.20M5.83M6.97M8.19M8.57M10.25M12.94M16.32M19.03M19.09M20.49M
Assets Average 93.27M145.59M215.60M284.74M268.97M248.36M223.69M194.21M243.03M291.14M258.62M229.48M318.84M405.30M372.11M342.67M307.17M281.25M333.64M386.05M364.08M327.81M332.07M343.47M295.70M320.25M372.71M377.92M389.48M379.71M439.80M
Equity Average 46.47M139.22M208.99M276.98M257.95M233.37M200.98M165.29M215.07M267.06M239.43M211.34M288.94M366.32M336.98M303.21M259.96M215.70M238.41M272.73M242.01M201.02M189.88M183.62M115.67M50.46M25.28M16.47M20.34M3.52M68.45M
Invested Capital -32.60M-51.86M144.79M133.66M284.32M269.64M246.26M220.49M181.47M149.12M281.02M253.10M225.75M196.94M380.95M351.69M322.26M284.15M235.77M229.90M354.16M264.26M219.76M182.28M197.47M169.76M61.58M39.34M11.21M23.27M20.54M-8.13M154.37M
Asset Utilization Ratio 0.010.020.050.050.060.090.130.190.230.310.320.300.340.350.410.40
Leverage & Solvency
Interest Coverage Ratio -18.31-13.98-17.16-14.11-13.96-9.07-29.42-8.79-8.37-7.57-8.69-7.79-11.10
Debt to Equity 0.000.000.000.635.055.78-9.220.73
Debt Ratio 0.010.000.000.320.280.280.290.21
Equity Ratio -2.65-1.490.950.960.970.970.950.930.860.840.910.920.930.910.900.910.910.860.830.700.720.690.640.590.560.510.240.100.030.060.05-0.030.29
Times Interest Earned -18.31-13.98-17.16-14.11-13.96-9.07-29.42-8.79-8.37-7.57-8.69-7.79-11.10
Valuation
Enterprise Value -10.76M-12.11M-8.95M-30.64M644.57M406.25M572.79M724.25M875.02M901.19M693.99M673.10M715.69M614.40M923.75M887.98M662.28M614.57M327.29M206.49M338.51M-26.79M894.53M1,307.25M717.47M683.61M1,004.88M2,440.49M2,404.23M2,183.96M2,903.95M3,119.34M2,826.08M3,573.80M5,927.69M
Market Capitalization 792.88M542.95M860.59M996.89M924.96M943.61M757.51M745.18M1,008.55M670.58M983.25M956.05M1,067.35M983.05M655.97M501.68M579.80M209.13M1,242.65M1,640.86M1,012.38M937.54M1,304.47M2,716.66M2,605.89M2,503.55M3,202.80M3,440.37M3,348.96M4,020.24M6,707.76M
Return Ratios
Return on Sales -24.60%-37.66%-13.67%-11.35%-7.64%-5.37%-4.16%-2.99%-2.39%-2.98%-2.55%-2.30%-2.00%-1.23%-1.17%-1.10%
Return on Capital Employed -0.37%-0.43%-0.57%-0.72%-0.82%-0.63%-0.52%-0.56%-0.64%-0.66%-0.64%-1.12%-1.00%-0.97%-1.01%-0.62%-0.71%-0.55%
Return on Invested Capital -0.93%-2.28%-28.60%
Return on Assets -0.14%-0.16%-0.23%-0.57%-0.65%-0.57%-0.47%-0.50%-0.56%-0.56%-0.54%-0.93%-0.81%-0.69%-0.69%-0.43%-0.48%-0.44%
Return on Equity -0.16%-0.17%-0.26%-0.67%-0.85%-0.79%-0.66%-0.75%-0.91%-0.98%-1.01%-2.37%-5.14%-10.24%-15.82%-8.30%-52.01%-2.81%